Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Induction of antigen-specific CD8+ T cells offers the prospect of immunization against many infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with efficacy in humans. Here we demonstrate that a replication-deficient chimpanzee adenovirus vector followed by a modifie...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Pub. Group
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868203/ |
id |
pubmed-3868203 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-38682032013-12-20 Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation Ewer, Katie J. O’Hara, Geraldine A. Duncan, Christopher J. A. Collins, Katharine A. Sheehy, Susanne H. Reyes-Sandoval, Arturo Goodman, Anna L. Edwards, Nick J. Elias, Sean C. Halstead, Fenella D. Longley, Rhea J. Rowland, Rosalind Poulton, Ian D. Draper, Simon J. Blagborough, Andrew M. Berrie, Eleanor Moyle, Sarah Williams, Nicola Siani, Loredana Folgori, Antonella Colloca, Stefano Sinden, Robert E. Lawrie, Alison M. Cortese, Riccardo Gilbert, Sarah C. Nicosia, Alfredo Hill, Adrian V. S. Article Induction of antigen-specific CD8+ T cells offers the prospect of immunization against many infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with efficacy in humans. Here we demonstrate that a replication-deficient chimpanzee adenovirus vector followed by a modified vaccinia virus Ankara booster induces exceptionally high frequency T-cell responses (median >2400 SFC/106 peripheral blood mononuclear cells) to the liver-stage Plasmodium falciparum malaria antigen ME-TRAP. It induces sterile protective efficacy against heterologous strain sporozoites in three vaccinees (3/14, 21%), and delays time to patency through substantial reduction of liver-stage parasite burden in five more (5/14, 36%), P=0.008 compared with controls. The frequency of monofunctional interferon-γ-producing CD8+ T cells, but not antibodies, correlates with sterile protection and delay in time to patency (Pcorrected=0.005). Vaccine-induced CD8+ T cells provide protection against human malaria, suggesting that a major limitation of previous vaccination approaches has been the insufficient magnitude of induced T cells. Nature Pub. Group 2013-11-28 /pmc/articles/PMC3868203/ /pubmed/24284865 http://dx.doi.org/10.1038/ncomms3836 Text en Copyright © 2013, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by-nc-by/3.0/ This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. To view a copy of this licence visit http://creativecommons.org/licenses/by/3.0/. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Ewer, Katie J. O’Hara, Geraldine A. Duncan, Christopher J. A. Collins, Katharine A. Sheehy, Susanne H. Reyes-Sandoval, Arturo Goodman, Anna L. Edwards, Nick J. Elias, Sean C. Halstead, Fenella D. Longley, Rhea J. Rowland, Rosalind Poulton, Ian D. Draper, Simon J. Blagborough, Andrew M. Berrie, Eleanor Moyle, Sarah Williams, Nicola Siani, Loredana Folgori, Antonella Colloca, Stefano Sinden, Robert E. Lawrie, Alison M. Cortese, Riccardo Gilbert, Sarah C. Nicosia, Alfredo Hill, Adrian V. S. |
spellingShingle |
Ewer, Katie J. O’Hara, Geraldine A. Duncan, Christopher J. A. Collins, Katharine A. Sheehy, Susanne H. Reyes-Sandoval, Arturo Goodman, Anna L. Edwards, Nick J. Elias, Sean C. Halstead, Fenella D. Longley, Rhea J. Rowland, Rosalind Poulton, Ian D. Draper, Simon J. Blagborough, Andrew M. Berrie, Eleanor Moyle, Sarah Williams, Nicola Siani, Loredana Folgori, Antonella Colloca, Stefano Sinden, Robert E. Lawrie, Alison M. Cortese, Riccardo Gilbert, Sarah C. Nicosia, Alfredo Hill, Adrian V. S. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
author_facet |
Ewer, Katie J. O’Hara, Geraldine A. Duncan, Christopher J. A. Collins, Katharine A. Sheehy, Susanne H. Reyes-Sandoval, Arturo Goodman, Anna L. Edwards, Nick J. Elias, Sean C. Halstead, Fenella D. Longley, Rhea J. Rowland, Rosalind Poulton, Ian D. Draper, Simon J. Blagborough, Andrew M. Berrie, Eleanor Moyle, Sarah Williams, Nicola Siani, Loredana Folgori, Antonella Colloca, Stefano Sinden, Robert E. Lawrie, Alison M. Cortese, Riccardo Gilbert, Sarah C. Nicosia, Alfredo Hill, Adrian V. S. |
author_sort |
Ewer, Katie J. |
title |
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
title_short |
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
title_full |
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
title_fullStr |
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
title_full_unstemmed |
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
title_sort |
protective cd8+ t-cell immunity to human malaria induced by chimpanzee adenovirus-mva immunisation |
description |
Induction of antigen-specific CD8+ T cells offers the prospect of immunization against many infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with efficacy in humans. Here we demonstrate that a replication-deficient chimpanzee adenovirus vector followed by a modified vaccinia virus Ankara booster induces exceptionally high frequency T-cell responses (median >2400 SFC/106 peripheral blood mononuclear cells) to the liver-stage Plasmodium falciparum malaria antigen ME-TRAP. It induces sterile protective efficacy against heterologous strain sporozoites in three vaccinees (3/14, 21%), and delays time to patency through substantial reduction of liver-stage parasite burden in five more (5/14, 36%), P=0.008 compared with controls. The frequency of monofunctional interferon-γ-producing CD8+ T cells, but not antibodies, correlates with sterile protection and delay in time to patency (Pcorrected=0.005). Vaccine-induced CD8+ T cells provide protection against human malaria, suggesting that a major limitation of previous vaccination approaches has been the insufficient magnitude of induced T cells. |
publisher |
Nature Pub. Group |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868203/ |
_version_ |
1612039989321793536 |